SPONSORED – Neuropathy is becoming a bigger problem for more people than ever before. If you`re suffering from stabbing pain, ...

At his practice on-site at Lebanon Internal Medicine Associates, Dr. Fishman utilizes advanced technology now offering ...

The study aims to evaluate the safety, tolerability and pharmacokinetics of FTX-101 versus placebo in healthy volunteers.

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

Parsonage-Turner syndrome following monkeypox infection is a rare form of peripheral neuropathy seen in orthopaedic practice ...

Wainzua had been previously approved for use by patients with ATTRv-PN in the United States, under the brand name Wainua.

According to the company, its data replicate and expand upon the potential of ER-100 to improve retinal ganglion cell ...

Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet ...

Sonnet BioTherapeutics Holdings, Inc. (SONN) announced Wednesday that it has entered into a licensing agreement with Alkem ...

Sonnet BioTherapeutics Holdings ( (SONN) ) has issued an update. Sonnet BioTherapeutics Holdings, Inc. has partnered with ...

The diabetic neuropathy market in India was valued at $120.3 million in 2023 and is projected to grow to $246.7 million by 2030. The global market for DPN treatment is expected to reach ...

(Alliance News) - AstraZeneca PLC on Monday said its Wainzua treatment has been been recommended for EU approval to treat ...